Evidence map›Paper›PMID 42298569›Full record

ArticleJournal of nanobiotechnology2026

Zn

Jingxia Xu, Zhenbin Dong, Wanting Yang, Fangming Zhang, Ying Xu, Guofeng Li, Xiaoyu Pan, Xing Wang, Wensheng Xie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jingxia XuState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
Zhenbin DongState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
Wanting YangState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
Fangming ZhangState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
Ying XuDepartment of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing, 100029, P. R. China.
Guofeng LiState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
Xiaoyu PanDepartment of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing, 100029, P. R. China. changpanxiaoyu@163.com.
Xing WangState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China. wangxing@mail.buct.edu.cn.
Wensheng XieState Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, P. R. China. xws@mail.buct.edu.cn.

Funding

National Natural Science Foundation of China 52273118, 22275013Natural Science Foundation of Beijing Municipality 2254093
6 · The paper itself

Abstract

Triple‑negative breast cancer (TNBC) poses substantial therapeutic challenges due to its innate resistance to apoptosis and lack of clearly characterized targets. Since necroptosis is the alternate pathway when apoptotic resistance develops, inducing necroptosis in tumor cells has become a promising therapeutic approach. Herein, this study proposes a calcium ions (Ca

Indexed as

CalciumNanoparticlesNaphthoquinonesNecroptosisReactive Oxygen SpeciesTriple Negative Breast NeoplasmsZincAnimalsAntineoplastic AgentsApoptosisCell Line, TumorFemaleHumansMiceAntineoplastic AgentsCalciumNaphthoquinonesReactive Oxygen SpeciesshikoninZincNecroptosisReactive Oxygen SpeciesShikoninTriple-Negative Breast CancerZinc/Calcium Co-overloaded

Identifiers

PMID42298569
PMCPMC13501617

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.